FDA Inspection 947903 — Centrient Pharmaceuticals Spain S.A.

Centrient Pharmaceuticals Spain S.A. — FEI 3003754230

The FDA completed an inspection of Centrient Pharmaceuticals Spain S.A. on September 25, 2015 in Santa Perpetua De Mogoda. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 25, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Santa Perpetua De Mogoda (Spain)